TQF3250 placebo

DRUG3 trials

Sponsors

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Conditions

HyperglycemiaOverweight/ObesityType 2 Diabetes Mellitus Combined With Overweight or Obesity

Phase 1

A Clinical Trial Evaluating TQF3250 Capsules in Healthy Adult Subjects

RecruitingNCT07327281

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Hyperglycemia

Start: 2025-12-18End: 2026-12-31Target: 66Updated: 2026-01-08

A Clinical Trial Evaluating TQF3250 Capsules in Patients With Type 2 Diabetes Mellitus and Overweight/Obesity

RecruitingNCT07747857

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Type 2 Diabetes Mellitus Combined With Overweight or Obesity

Start: 2026-08-25End: 2027-07-01Target: 72Updated: 2026-08-28

A Clinical Trial of TQF3250 Capsules in Overweight/Obese Trial Participants With Poor Weight Control Through Simple Lifestyle Intervention

Not yet recruitingNCT07798284

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Overweight/Obesity

Start: 2026-09-01End: 2027-04-01Target: 80Updated: 2026-09-01